US Patent Issued to Prelude Therapeutics on Oct. 14 for "Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)" (American, Spanish Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,506, issued on Oct. 14, was assigned to Prelude Therapeutics Inc. (Wilmington, Del.).

"Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)" was invented by Hong Lin (Exton, Pa.), Juan Luengo (Phoenixville, Pa.), Rupa Shetty (Blue Bell, Pa.), Michael Hawkins (Ambler, Pa.), Philip Pitis (North Wales, Pa.) and Gisela Saborit Villarroya (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to methods of treatment using compounds of Formula (I)."

The patent was filed on April 3, 2020, under Application No. 17/601,485.

*For further information, including images, charts and tables, please visit: http...